Rothschild Redburn downgrades Accenture stock rating to Neutral on AI growth concerns

Rothschild Redburn downgraded Accenture (ACN) to Neutral with a $250 price target, citing concerns that strong generative AI bookings are being overshadowed by broader business weaknesses, as evidenced by Q3 FY25 organic revenue growth of 5%—half its pre-pandemic average—and anticipated federal contract headwinds. Despite this, Accenture reported a 12% Q3 EPS increase and 7% revenue growth, maintains strong financial health, and continues strategic investments in AI and marketing capabilities.

Analysis

Accenture (ACN) faces a mixed outlook following a downgrade to Neutral from Buy by Rothschild Redburn, which set a $250 price target. The downgrade is predicated on concerns that slowing growth in core business areas is offsetting gains from generative AI. This is evidenced by third-quarter fiscal 2025 organic revenue growth of 5%, approximately half of its pre-pandemic average, and an anticipated 2-percentage-point headwind from slowing federal government contracts. The bearish sentiment is further supported by five analysts revising earnings estimates downward, even as Accenture is well-positioned to capture AI spending. In contrast to these headwinds, the company reported strong Q3 FY25 results, with a 12% year-over-year increase in earnings per share to $3.49 and 7% revenue growth to $17.7 billion. Furthermore, Accenture maintains robust financial health, indicated by an Altman Z-Score of 9.78 and moderate debt levels. The company is also actively pursuing strategic growth through an investment in AI compression platform CLIKA and the acquisition of marketing agency Superdigital, reinforcing its capabilities in intelligent edge and creative services.

Key Decisions for Investors

• Investors should closely monitor future organic revenue growth figures, using the reported 5% as a benchmark to assess whether the slowdown in non-AI segments is a persistent trend or a temporary trough.
• Given the Rothschild Redburn downgrade and downward revisions from other analysts, the stock may face near-term valuation pressure; it may be prudent to await further clarity on the impact of federal contract headwinds before initiating new positions.
• Long-term holders can take comfort in the company's strong financial health and strategic acquisitions in AI and marketing, but should watch for signs that these investments are translating into an acceleration of overall growth to offset the current deceleration.